Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β

Platelet-derived growth factor (PDGF) has been implicated in the pathobiology of vascular remodeling. The multikinase inhibitor imatinib that targets PDGF receptor (PDGFR), c-kit and Abl kinases, shows therapeutic efficacy against experimental pulmonary hypertension (PH); however, the role of PDGFR-...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dahal, Bhola K., Heuchel, Rainer, Pullamsetti, Soni Savai, Wilhelm, Jochen, Ghofrani, Hossein A., Weissmann, Norbert, Seeger, Werner, Grimminger, Friedrich, Schermuly, Ralph T.
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications 2011
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198653/
https://ncbi.nlm.nih.gov/pubmed/22034611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.83448
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items